Dizal Announces Phase 3 WU-KONG28 Results: ZEGFROVY (Sunvozertinib) Outperforms Platinum-Doublet Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation-Positive Non-Small Cell Lung Cancer